A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)
Clinical trial NCT03697265 · COMPLETED
Trial details
- NCT number
- NCT03697265
- Sponsor
- Asarina Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-20
- Primary completion
- 2020-07-28
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.